TULIPIFERA STRATEGIES

Lobbying for TREATMENT ADVOCACY CENTER · Advocacy, education, and research related to eliminating barriers to the treatment of SMI.

Filing Registration

2nd Quarter (Apr 1 - June 30) 2025 · Virginia · posted Jul 1, 2025

Lobbying activity 1

Health Issues

Issues related to eliminating barriers to treatment of severe mental illness, including the Medicaid IMD exclusion.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.